Vertex Pharmaceuticals Incorporated (VRTX)

258.59
NASDAQ
Prev Close 255.45
Day Low/High 252.51 / 259.10
52 Wk Low/High 176.36 / 292.75
Exchange NASDAQ
Shares Outstanding 255.76B
Market Cap 65.33B
P/E Ratio 23.27
Div & Yield N.A. (N.A)

Latest News

Long Story Short: This First Trust ETF Has a Lot to Like

Long Story Short: This First Trust ETF Has a Lot to Like

Let's take a deep dive into the First Trust Long/Short Equity exchange-traded fund, which looks to make gains on shorted stocks as well as additional profit from levered positions.

How Far Can Vertex Pharmaceuticals Rally?

How Far Can Vertex Pharmaceuticals Rally?

Let's check the charts for the answer.

These ETFs Aim for the 'MOON,' but Will They Crash and Burn?

These ETFs Aim for the 'MOON,' but Will They Crash and Burn?

Here's my take on several 'innovation' funds -- and which one might be the best bet.

Vertex Pharmaceuticals Raised at BMO

Vertex Pharmaceuticals Is Rallying and Gets a Quant Upgrade

Vertex Pharmaceuticals Is Rallying and Gets a Quant Upgrade

The stock has broken a long-term downtrend, which gets my attention.

Vertex Pharmaceuticals Is in a Long-Term Decline

Vertex Pharmaceuticals Is in a Long-Term Decline

But the worst appears to be behind them.

Insider Buying Picks Up in These Biotech Stocks

Insider Buying Picks Up in These Biotech Stocks

The beaten-down biotech sector had one of the best weeks in a year. Are these names still oversold?

Bearish Bets: 2 Nasdaq Stocks You Should Consider Shorting This Week

Bearish Bets: 2 Nasdaq Stocks You Should Consider Shorting This Week

These recently downgraded names are displaying both quantitative and technical deterioration.

2 Small Stocks to Watch as Conditions Ripen for Biotech Merger Deals

2 Small Stocks to Watch as Conditions Ripen for Biotech Merger Deals

Ardelyx Inc. and Rigel Pharmaceuticals look good as stand-alone companies but also could attract suitors.

Wait a Few Days to Trade Vertex So You Don't Get Your Face Ripped Off

Wait a Few Days to Trade Vertex So You Don't Get Your Face Ripped Off

While it's tempting to take on a long-side trade here, I don't see a good reason.

Markets Focused on Relief Package, Price Is No Longer Truth, 'Unhedged Funds'

Markets Focused on Relief Package, Price Is No Longer Truth, 'Unhedged Funds'

Let's not kid ourselves that there is any longer some kind of relationship between price and value. Or fact and truth.

Vertex Rated New Outperform at Daiwa

Vertex Rated New Outperform at Bernstein

A Healthy Dose of Vaccine and Pharmaceutical Plays

A Healthy Dose of Vaccine and Pharmaceutical Plays

6 favorite stocks and ETFs in the biotech and pharmaceutical sector, including a diversified basket of Covid-19 vaccine names.

Here's How Patient Investors Could Buy Vertex Pharmaceuticals

Here's How Patient Investors Could Buy Vertex Pharmaceuticals

The short-term charts of VRTX suggest that this stock can see further sideways to lower price action in the weeks ahead.

Vertex Pharma Appears on a Healthy Trajectory

Vertex Pharma Appears on a Healthy Trajectory

Investors should continue to hold their positions on VRTX.

Earnings in Full Swing, Workplace Evolution, Fed Day

Earnings in Full Swing, Workplace Evolution, Fed Day

There was a mild increase in trading volume at the New York Stock Exchange, but it was a rotational shift.

Jim Cramer: Oil Tanked, and We're in Uncharted Waters

Jim Cramer: Oil Tanked, and We're in Uncharted Waters

Oil isn't really worthless and Amazon isn't the only retailer that will survive, but we are in a mixed up market thanks to Covid-19.

Vertex Pharmaceuticals Could See More Gains but Weaker Momentum Is a Risk

Vertex Pharmaceuticals Could See More Gains but Weaker Momentum Is a Risk

The pace of the rally in the drugmaker's shares is slowing, which is one reason to keep an eye on its stock.

Don't Underestimate Vertex Pharmaceuticals

Don't Underestimate Vertex Pharmaceuticals

Here's how the stock might surprise Wall Street.

Vertex Pharmaceuticals: The 'Endpoint' Is a Bullish Golden Cross

Vertex Pharmaceuticals: The 'Endpoint' Is a Bullish Golden Cross

VRTX is poised for further upside price gains.

The Technical Profile of This Market Remains Positive

The Technical Profile of This Market Remains Positive

The indices are within striking distance of the July highs after moving into position for a possible strong finish to the year.

Jim Cramer: These Are the Stocks to Buy on Canada Deal and the 4th Quarter

Jim Cramer: These Are the Stocks to Buy on Canada Deal and the 4th Quarter

Straying from these names could land you in quicksand as the 4th quarter begins.

Jim Cramer: 5 Sectors to Buy on This 'Turkish Contagion' Market Drop

Jim Cramer: 5 Sectors to Buy on This 'Turkish Contagion' Market Drop

It is all about perception, and here are strong names to pick up on market weakness.

2 Trading Opportunities in Health Care

2 Trading Opportunities in Health Care

The potential of these setups on the weekly chart is rather good.

Trying the Long Side of Vertex's Stock Again

Trying the Long Side of Vertex's Stock Again

After pharmaceutical company breaks out, charts suggest now is the time to go back in.

Cramer: 2017 Was a Year of Resurrection and Revival

Cramer: 2017 Was a Year of Resurrection and Revival

Look no further than the top 10 winners in the S&P 500 and you will see just what I mean.